149 related articles for article (PubMed ID: 28608394)
1. A discovery-driven approach to elucidate urinary metabolome changes after a regular and moderate consumption of beer and nonalcoholic beer in subjects at high cardiovascular risk.
Quifer-Rada P; Chiva-Blanch G; Jáuregui O; Estruch R; Lamuela-Raventós RM
Mol Nutr Food Res; 2017 Oct; 61(10):. PubMed ID: 28608394
[TBL] [Abstract][Full Text] [Related]
2. Urinary isoxanthohumol is a specific and accurate biomarker of beer consumption.
Quifer-Rada P; Martínez-Huélamo M; Chiva-Blanch G; Jáuregui O; Estruch R; Lamuela-Raventós RM
J Nutr; 2014 Apr; 144(4):484-8. PubMed ID: 24477299
[TBL] [Abstract][Full Text] [Related]
3. Exercise testing in metabolic myopathies.
Tarnopolsky M
Phys Med Rehabil Clin N Am; 2012 Feb; 23(1):173-86, xii. PubMed ID: 22239882
[TBL] [Abstract][Full Text] [Related]
4. Epicardial adipose tissue GLP-1 receptor is associated with genes involved in fatty acid oxidation and white-to-brown fat differentiation: A target to modulate cardiovascular risk?
Dozio E; Vianello E; Malavazos AE; Tacchini L; Schmitz G; Iacobellis G; Corsi Romanelli MM
Int J Cardiol; 2019 Oct; 292():218-224. PubMed ID: 31023563
[TBL] [Abstract][Full Text] [Related]
5. Management of fatty acid oxidation disorders: a survey of current treatment strategies.
Solis JO; Singh RH
J Am Diet Assoc; 2002 Dec; 102(12):1800-3. PubMed ID: 12487544
[TBL] [Abstract][Full Text] [Related]
6. Histidine-450 is the catalytic residue of L-3-hydroxyacyl coenzyme A dehydrogenase associated with the large alpha-subunit of the multienzyme complex of fatty acid oxidation from Escherichia coli.
He XY; Yang SY
Biochemistry; 1996 Jul; 35(29):9625-30. PubMed ID: 8755745
[TBL] [Abstract][Full Text] [Related]
7. New fatty acid oxidation inhibitors with increased potency lacking adverse metabolic and electrophysiological properties.
Koltun DO; Marquart TA; Shenk KD; Elzein E; Li Y; Nguyen M; Kerwar S; Zeng D; Chu N; Soohoo D; Hao J; Maydanik VY; Lustig DA; Ng KJ; Fraser H; Zablocki JA
Bioorg Med Chem Lett; 2004 Jan; 14(2):549-52. PubMed ID: 14698201
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of long-chain fatty acid oxidation disorders using alternative precursors and acylcarnitine profiling in fibroblasts.
Roe DS; Yang BZ; Vianey-Saban C; Struys E; Sweetman L; Roe CR
Mol Genet Metab; 2006 Jan; 87(1):40-7. PubMed ID: 16297647
[TBL] [Abstract][Full Text] [Related]
9. Rewired metabolism in drug-resistant leukemia cells: a metabolic switch hallmarked by reduced dependence on exogenous glutamine.
Stäubert C; Bhuiyan H; Lindahl A; Broom OJ; Zhu Y; Islam S; Linnarsson S; Lehtiö J; Nordström A
J Biol Chem; 2015 Mar; 290(13):8348-59. PubMed ID: 25697355
[TBL] [Abstract][Full Text] [Related]
10. Increase in omega-6 and decrease in omega-3 polyunsaturated fatty acid oxidation elevates the risk of exudative AMD development in adults with Chinese diet.
Leung HH; Ng AL; Durand T; Kawasaki R; Oger C; Balas L; Galano JM; Wong IY; Chung-Yung Lee J
Free Radic Biol Med; 2019 Dec; 145():349-356. PubMed ID: 31605749
[TBL] [Abstract][Full Text] [Related]
11. Effect of high-intensity intermittent swimming training on fatty acid oxidation enzyme activity in rat skeletal muscle.
Terada S; Tabata I; Higuchi M
Jpn J Physiol; 2004 Feb; 54(1):47-52. PubMed ID: 15040848
[TBL] [Abstract][Full Text] [Related]
12. Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alpha.
Gerhart-Hines Z; Rodgers JT; Bare O; Lerin C; Kim SH; Mostoslavsky R; Alt FW; Wu Z; Puigserver P
EMBO J; 2007 Apr; 26(7):1913-23. PubMed ID: 17347648
[TBL] [Abstract][Full Text] [Related]
13. (1)H-NMR-based metabolomic analysis of the effect of moderate wine consumption on subjects with cardiovascular risk factors.
Vázquez-Fresno R; Llorach R; Alcaro F; Rodríguez MÁ; Vinaixa M; Chiva-Blanch G; Estruch R; Correig X; Andrés-Lacueva C
Electrophoresis; 2012 Aug; 33(15):2345-54. PubMed ID: 22887155
[TBL] [Abstract][Full Text] [Related]
14. Effects of long-chain monounsaturated and n-3 fatty acids on fatty acid oxidation and lipid composition in rats.
Halvorsen B; Rustan AC; Madsen L; Reseland J; Berge RK; Sletnes P; Christiansen EN
Ann Nutr Metab; 2001; 45(1):30-7. PubMed ID: 11244185
[TBL] [Abstract][Full Text] [Related]
15. Exploring options for expanded newborn screening.
Baily MA; Becker W; Hayes M; Clayton EW; Grosse S
J Law Med Ethics; 2005; 33(4 Suppl):46-8. PubMed ID: 16689158
[No Abstract] [Full Text] [Related]
16. Incidence and short-term outcome of children with symptomatic presentation of organic acid and fatty acid oxidation disorders in Germany.
Klose DA; Kölker S; Heinrich B; Prietsch V; Mayatepek E; von Kries R; Hoffmann GF
Pediatrics; 2002 Dec; 110(6):1204-11. PubMed ID: 12456920
[TBL] [Abstract][Full Text] [Related]
17. Structure of mycobacterial β-oxidation trifunctional enzyme reveals its altered assembly and putative substrate channeling pathway.
Venkatesan R; Wierenga RK
ACS Chem Biol; 2013 May; 8(5):1063-73. PubMed ID: 23496842
[TBL] [Abstract][Full Text] [Related]
18. Detecting Beer Intake by Unique Metabolite Patterns.
Gürdeniz G; Jensen MG; Meier S; Bech L; Lund E; Dragsted LO
J Proteome Res; 2016 Dec; 15(12):4544-4556. PubMed ID: 27781435
[TBL] [Abstract][Full Text] [Related]
19. MSC-induced lncRNA HCP5 drove fatty acid oxidation through miR-3619-5p/AMPK/PGC1α/CEBPB axis to promote stemness and chemo-resistance of gastric cancer.
Wu H; Liu B; Chen Z; Li G; Zhang Z
Cell Death Dis; 2020 Apr; 11(4):233. PubMed ID: 32300102
[TBL] [Abstract][Full Text] [Related]
20. Characterization of L-aminocarnitine, an inhibitor of fatty acid oxidation.
Chegary M; Te Brinke H; Doolaard M; Ijlst L; Wijburg FA; Wanders RJ; Houten SM
Mol Genet Metab; 2008 Apr; 93(4):403-10. PubMed ID: 18077198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
